"After listening closely to Timothy Aitman of the Imperial College of London, it seems to me that the market for DTC is not in the United States.

It is in Jolly 'Ol England. "

One of my readers sent this to me today and I laughed and laughed.

Why?

I am filling out an abstract that I will present to the GAPPNET meeting in Michigan.

It is about media response and attitudinal change to these companies correlated to my blog posts......

So what does Jolly 'Ol Anne and Bloody Sergey plan to do for Londoners????

"Ms Wojcicki said that it would be especially important for companies like hers to work with doctors to interpret genomic information, as the costs of DNA sequencing fall further. It is widely predicted that it will be possible to sequence anybody’s entire genome for less than £1,000 within a year or two, to reveal genetic variations that influence disease risk and response to drugs."

Ahhh, now you want to work with doctors Eh? Maybe listening to Mari Baker a little???? Physician distribution centers......

OMG, Dietrich, did you tell them our plan????

Well, count me in. As long as you come on bended knee. I will hear what you have to say. But then you have to hear what I am to say as well........

I have been getting CPMC data, this is no different, except the lack of IRB, the potential of bankruptcy sales of my data, the pootential of google linking this data to my gmail account etc.